Sonic Fund II L.P. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-17
10:39 am
Purchase
2025-12-3113GFENNEC PHARMACEUTICALS, INC. O
FENC
Sonic Fund II L.P.2,799,959
8.200%
330,079increase
(+13.36%)
Filing
History
2022-12-30
4:11 pm
Sale
2022-12-2713DADVERUM BIOTECHNOLOGIES INC CO
ADVM
Sonic Fund II L.P.463,143
4.600%
-200,000decrease
(-30.16%)
Filing
History
2022-02-14
09:08 am
Sale
2021-12-3113GFENNEC PHARMACEUTICALS, INC. O
FENC
Sonic Fund II L.P.2,469,880
9.500%
-25,873decrease
(-1.04%)
Filing
History